Lilly's tirzepatidein in February helped up to 74% of patients achieve absence of MASH with no worsening of liver scarring at 52 weeks, compared with 13% of patients on placebo, in a mid-stage trial
In fact, demand for GLP-1 therapies has grown so rapidly that the World Health Organization (WHO) issued an advisory to its members last December, warning of the spread of falsified and substandard products that threaten patient safety and public trust
Other alternatives to Contrave or Wegovy include: Ozempic (semaglutide): once-weekly injection approved for people with type 2 diabetes, sometimes used off-label for weight loss Rybelsus (semaglutide): oral semaglutide tablet taken once daily Victoza ( liraglutide ): daily diabetes injection, available in a lower-cost generic version Metformin : generic diabetes medication that has shown modest amounts of weight loss in clinical studies , though it isnt approved for weight management
The net result varies by individual
Hims just held its Q2 earnings call, and well center the bulk of the conversation and controversy around them given the public availability of information along with the amount of discussion GLP-1s generated during the Q&A
It will take more time to determine how effective the pill is in supporting patients' long-term weight loss journeys, whether it helps keep users on GLP-1s for longer than injections do and whether demand for Novo's product will hold in the face of fresh competition from Eli Lilly
